News
Media
Conferences
CME/CE
Partners
Publications
Resources
Subscribe

Headache and Migraine

Latest News

Latest Videos

Jessica Ailani, MD: Lowering the Opioid Use Rates in Migraine

Jessica Ailani, MD: Lowering the Opioid Use Rates in Migraine

Susan Hutchinson, MD: The Potential of the Gepant Class in Acute Migraine

Susan Hutchinson, MD: The Potential of the Gepant Class in Acute Migraine

Christopher Gottschalk, MD: Advantages of Eptinezumab and CGRP Inhibitors

Christopher Gottschalk, MD: Advantages of Eptinezumab and CGRP Inhibitors

Dawn Buse, PhD: Where Are Patients With Migraine Seeking Care?

Dawn Buse, PhD: Where Are Patients With Migraine Seeking Care?

Richard Lipton, MD: Eptinezumab Maintains Reductions in the Impact of Migraine

Richard Lipton, MD: Eptinezumab Maintains Reductions in the Impact of Migraine

Deborah Friedman, MD, MPH: Telemedicine for Headache Disorders

Deborah Friedman, MD, MPH: Telemedicine for Headache Disorders

Jessica Ailani, MD: Long-Term Safety and Efficacy of Ubrogepant in Acute Migraine

Jessica Ailani, MD: Long-Term Safety and Efficacy of Ubrogepant in Acute Migraine

Marisa McGinley, DO: Advantages of Outpatient Telemedicine in Neurology Subspecialties

Marisa McGinley, DO: Advantages of Outpatient Telemedicine in Neurology Subspecialties

Peter Goadbsy, MD, PhD, DSc: Atogepant Has Potential as Migraine Prophylactic

Peter Goadbsy, MD, PhD, DSc: Atogepant Has Potential as Migraine Prophylactic

Emerging Topics in Neurology

Emerging Topics in Neurology

CME Content

Increasing Awareness of Therapeutic Options for Thymidine Kinase 2 Deficiency (TK2d)

Increasing Awareness of Therapeutic Options for Thymidine Kinase 2 Deficiency (TK2d)

Michio Hirano, MD; Mary Kay Koenig, MD; Zarazuela Zolkipli-Cunningham, MBChB, MRCP

How Do I Identify MOGAD? Improving Outcomes Through Early Identification of Patients

How Do I Identify MOGAD? Improving Outcomes Through Early Identification of Patients

Michael Levy, MD, PhD; Jeffrey L. Bennett, MD, PhD; Eoin P. Flanagan, MB, BCh

More News

Patient Selection for Acute Migraine Therapy

ByRobert Cowan, MD,David W. Dodick, MD

October 30th 2020

Acute Migraine Treatment Goals

ByRobert Cowan, MD,David W. Dodick, MD

October 30th 2020

Treatment Goals for Acute Migraine

ByRobert Cowan, MD,David W. Dodick, MD

October 30th 2020

Treating Acute Migraine in the Community Setting

ByRobert Cowan, MD,David W. Dodick, MD

October 30th 2020

Acute Migraine Treatment: What’s Next?

ByRobert Cowan, MD,David W. Dodick, MD

October 30th 2020

Real-World Experience With Gepants for Acute Migraine

ByRobert Cowan, MD,David W. Dodick, MD

October 30th 2020

Gepants for Acute Migraine: Patient Management

ByRobert Cowan, MD,David W. Dodick, MD

October 30th 2020

Gepants for Acute Migraine: Safety & Efficacy Data

ByRobert Cowan, MD,David W. Dodick, MD

October 30th 2020

Advances in the Treatment of Acute Migraine

ByRobert Cowan, MD,David W. Dodick, MD

October 30th 2020

Burden of Migraine

ByRobert Cowan, MD,David W. Dodick, MD

October 30th 2020

Jennifer Frontera, MD: Neurologic Implications of COVID-19 Infection

ByJennifer Frontera, MD

October 30th 2020

The professor of neurology at the NYU Langone Grossman School of Medicine gave her reaction to the data she and colleagues published on neurologic disorders in patients with COVID-19.

Behavioral and Lifestyle Strategies for Migraine Management

ByPeter J. Goadsby, MD, PhD, DSc,Dawn C. Buse, PhD,Jelena Pavlovic, MD, PhD,Wade M. Cooper, DO,Paul G. Mathew, MD, DNPAS, FAAN, FAHS

October 28th 2020

Patient Selection for Neuromodulation Devices

ByPeter J. Goadsby, MD, PhD, DSc,Dawn C. Buse, PhD,Jelena Pavlovic, MD, PhD,Wade M. Cooper, DO,Paul G. Mathew, MD, DNPAS, FAAN, FAHS

October 28th 2020

Role of Neuromodulation for Acute Treatment of Migraine

ByPeter J. Goadsby, MD, PhD, DSc,Dawn C. Buse, PhD,Jelena Pavlovic, MD, PhD,Wade M. Cooper, DO,Paul G. Mathew, MD, DNPAS, FAAN, FAHS

October 28th 2020

Patient Selection of Novel Therapies for Migraine Treatment

ByPeter J. Goadsby, MD, PhD, DSc,Dawn C. Buse, PhD,Jelena Pavlovic, MD, PhD,Wade M. Cooper, DO,Paul G. Mathew, MD, DNPAS, FAAN, FAHS

October 28th 2020

Intranasal DHE in Acute Treatment of Migraine

ByPeter J. Goadsby, MD, PhD, DSc,Dawn C. Buse, PhD,Jelena Pavlovic, MD, PhD,Wade M. Cooper, DO,Paul G. Mathew, MD, DNPAS, FAAN, FAHS

October 28th 2020

Safety of CGRP Receptor Antagonists vs 5-HT1F Agonists

ByPeter J. Goadsby, MD, PhD, DSc,Dawn C. Buse, PhD,Jelena Pavlovic, MD, PhD,Wade M. Cooper, DO,Paul G. Mathew, MD, DNPAS, FAAN, FAHS

October 28th 2020

Use of 5-HT1F Agonists in Acute Treatment of Migraine

ByPeter J. Goadsby, MD, PhD, DSc,Dawn C. Buse, PhD,Jelena Pavlovic, MD, PhD,Wade M. Cooper, DO,Paul G. Mathew, MD, DNPAS, FAAN, FAHS

October 28th 2020

Acute Treatment of Migraine: Progress With Novel Medications

ByPeter J. Goadsby, MD, PhD, DSc,Dawn C. Buse, PhD,Jelena Pavlovic, MD, PhD,Wade M. Cooper, DO,Paul G. Mathew, MD, DNPAS, FAAN, FAHS

October 28th 2020

Evolution of Acute Treatment of Migraine

ByPeter J. Goadsby, MD, PhD, DSc,Dawn C. Buse, PhD,Jelena Pavlovic, MD, PhD,Wade M. Cooper, DO,Paul G. Mathew, MD, DNPAS, FAAN, FAHS

October 28th 2020

Acute Treatment of Migraine: Traditional Therapies

ByPeter J. Goadsby, MD, PhD, DSc,Dawn C. Buse, PhD,Jelena Pavlovic, MD, PhD,Wade M. Cooper, DO,Paul G. Mathew, MD, DNPAS, FAAN, FAHS

October 28th 2020

Unmet Needs in the Management of Migraine

ByPeter J. Goadsby, MD, PhD, DSc,Dawn C. Buse, PhD,Jelena Pavlovic, MD, PhD,Wade M. Cooper, DO,Paul G. Mathew, MD, DNPAS, FAAN, FAHS

October 28th 2020

Nerivio Device Granted Clearance for Acute Treatment of Chronic Migraine

October 26th 2020

The Theranica Biotherapeutics remote electrical neuromodulation device is now cleared for the acute treatment of migraine with or without aura in adults, without limitation to episodic migraine.

FDA Issues Complete Response Letter for Zolmitriptan

October 26th 2020

Zosano plans to request a Type A meeting with the FDA to discuss strategies to address the FDA’s comments regarding the new drug application.

This Week on NeurologyLive

ByNeurologyLive® Staff

October 26th 2020

Here's what is coming soon to NeurologyLive.

Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights

FDA Approves Factor XIa Inhibitor Asundexian for Secondary Stroke Prevention

FDA Investigates Confirmed Insertional Oncogenesis With Spinal Muscular Atrophy Gene Therapy

Identifying the Biggest Neuromuscular Advocacy Challenges for 2027: Paul Melmeyer, MPP

Examining High-Dose Influenza Vaccination and Alzheimer Disease Risk

Consistent TAPS Use Associated With Underlying Tremor Improvement in Essential Tremor